Ulrich A Walker Selected Research

Zalcitabine (Hivid)

12/2010	Role of pyrimidine depletion in the mitochondrial cardiotoxicity of nucleoside analogue reverse transcriptase inhibitors.
1/2010	Oral uridine supplementation antagonizes the peripheral neuropathy and encephalopathy induced by antiretroviral nucleoside analogues.
1/2008	Uridine supplementation antagonizes zidovudine-induced mitochondrial myopathy and hyperlactatemia in mice.
1/2007	Uridine supplementation antagonizes zalcitabine-induced microvesicular steatohepatitis in mice.
10/2003	Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
11/2002	Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ulrich A Walker Research Topics

Disease

10	Rheumatoid Arthritis 12/2021 - 01/2009
10	Systemic Scleroderma (Systemic Sclerosis) 11/2020 - 03/2013
8	Mitochondrial Diseases (Mitochondrial Disease) 02/2011 - 10/2003
7	Cardiomyopathies (Cardiomyopathy) 11/2019 - 11/2003
5	Cardiotoxicity 12/2010 - 01/2007
4	Infections 10/2021 - 02/2004
4	Fibrosis (Cirrhosis) 03/2021 - 06/2014
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 11/2013
3	Diphtheria 01/2022 - 01/2017
3	Tetanus 01/2022 - 01/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021 - 05/2008
3	Inflammation (Inflammations) 01/2017 - 01/2012
3	Muscular Diseases (Myopathy) 01/2017 - 01/2008
3	Telangiectasis (Telangiectasia) 06/2014 - 11/2013
3	Hyperlactatemia 01/2008 - 02/2004
3	Fatty Liver 07/2007 - 11/2002
3	Hepatocellular Carcinoma (Hepatoma) 01/2007 - 11/2002
2	Chronic Renal Insufficiency 01/2022 - 03/2013
2	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2019
2	Cryopyrin-Associated Periodic Syndromes 01/2021 - 06/2018
2	Hypertrophy 01/2020 - 01/2014
2	Giant Cell Arteritis (Horton Disease) 10/2017 - 05/2008
2	Ischemia 01/2015 - 10/2012
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2014 - 06/2014
2	Lipodystrophy 01/2014 - 07/2011
2	Pulmonary Arterial Hypertension 11/2013 - 11/2013
2	Mitochondrial Myopathies (Mitochondrial Myopathy) 10/2012 - 01/2008
2	Atrophy 10/2012 - 10/2012
2	Vasculitis (Vasculitides) 02/2012 - 05/2008
2	Lactic Acidosis 05/2008 - 11/2002
1	Gout 01/2022
1	Hyperuricemia 01/2022
1	Thrombosis (Thrombus) 12/2021
1	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2020
1	Osteoarthritis 01/2020
1	Premature Aging 01/2020
1	Knee Osteoarthritis 01/2020
1	COVID-19 01/2020
1	Heart Failure 11/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 11/2019
1	Reperfusion Injury 01/2019
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Urticaria (Hives) 08/2017
1	Fever (Fevers) 08/2017
1	Exanthema (Rash) 08/2017
1	Human Influenza (Influenza) 01/2017
1	Muscle Weakness 01/2017

Drug/Important Bio-Agent (IBA)

22	Mitochondrial DNA (mtDNA)IBA 12/2021 - 11/2002
9	Zidovudine (Retrovir)FDA LinkGeneric 01/2014 - 11/2002
8	UridineIBA 02/2011 - 10/2003
6	AntibodiesIBA 01/2022 - 03/2013
6	Rituximab (Mabthera)FDA Link 01/2020 - 05/2008
6	Zalcitabine (Hivid)FDA Link 12/2010 - 11/2002
6	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2010 - 11/2003
5	AutoantibodiesIBA 01/2019 - 05/2010
5	NucleosidesIBA 10/2012 - 01/2008
4	Reverse Transcriptase InhibitorsIBA 10/2012 - 01/2008
3	VaccinesIBA 01/2022 - 04/2012
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 01/2007
3	Oxygen (Dioxygen)IBA 01/2015 - 10/2012
3	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 10/2012 - 02/2007
3	Pharmaceutical PreparationsIBA 01/2007 - 11/2003
3	Stavudine (Zerit)FDA LinkGeneric 01/2007 - 11/2002
2	Diphtheria-Tetanus VaccineIBA 01/2022 - 01/2019
2	Anti-Citrullinated Protein AntibodiesIBA 10/2021 - 01/2017
2	InterleukinsIBA 01/2021 - 01/2012
2	Polysaccharides (Glycans)IBA 06/2018 - 04/2012
2	C-Reactive ProteinIBA 01/2017 - 01/2012
2	pyrimidineIBA 12/2010 - 01/2008
2	Superoxides (Superoxide)IBA 02/2007 - 11/2003
2	AnthracyclinesIBA 01/2007 - 12/2005
2	Didanosine (Videx)FDA LinkGeneric 01/2007 - 11/2002
2	Lamivudine (Epivir)FDA Link 01/2007 - 11/2002
1	Uric Acid (Urate)IBA 01/2022
1	Biological ProductsIBA 12/2021
1	NexusIBA 12/2021
1	Cell-Free Nucleic AcidsIBA 12/2021
1	Immunoglobulin G (IgG)IBA 10/2021
1	anti-scl-70 autoantibodiesIBA 03/2021
1	canakinumab FDA Link 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Proteoglycans (Proteoglycan)IBA 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2019
1	Vasodilator Agents (Vasodilators)IBA 11/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	LectinsIBA 01/2019
1	tocilizumab (atlizumab)FDA Link 10/2017
1	InflammasomesIBA 08/2017
1	Proteins (Proteins, Gene)FDA Link 03/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Fructose-Bisphosphate Aldolase (Aldolase)IBA 01/2017
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2017
1	AntigensIBA 01/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 02/2004
2	Lasers (Laser) 01/2015 - 12/2014
2	Art Therapy 07/2010 - 01/2009
1	Length of Stay 01/2022
1	Hematopoietic Stem Cell Transplantation 01/2021
1	Stem Cell Transplantation 01/2018